![De Gui Lai](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 27 M $ al 31/05/2026
De Gui Lai ocupa el puesto de Director Financiero y Contable, Subdirector General de Sichuan Kelun Pharmaceutical Co., Ltd. y Director de Finanzas y Contabilidad de Chengdu Nymph Group Co.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/04/2025 | 465.000 ( 0,27 % ) | 27 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| SICHUAN KELUN PHARMACEUTICAL CO., LTD. | Director Financiero/CFO | 23/10/2014 |
| SICHUAN KELUN-BIOTECH BIOPHARMACEUTICAL CO., LTD. | Director/Miembro de la Junta | 20/06/2024 |
Chengdu Nymph Group Co., Ltd.
 Chengdu Nymph Group Co., Ltd. Chengdu Nymph Group Co., Ltd. is a large integrated joint-stock enterprise specializing in the research, development, production, and sales of daily chemical products, focusing primarily on detergents and personal care products. The company integrates advanced production technology with traditional herbal knowledge and collaborates with institutions like Chengdu University of Traditional Chinese Medicine. The company is based in Chengdu, China. The Chinese company operates two major production bases, employs over 580 people including more than 220 technical professionals, and holds multiple production licenses and certifications such as ISO9001, ISO14001, and ISO45001. Its brands include detergent lines like "Red Rose," "Red Hibiscus," and "Double Cat," as well as cosmetic and personal care brands such as "Chunjuan," "Chunjuan Huangqi," "Chunjuan Baby," "Forest Morning," "Urban Baby," and "Dushi Beibei." Its marketing network covers over 235,000 sales outlets nationwide, with detergents mainly distributed in the southwest and cosmetics reaching all provinces. | Director Financiero/CFO | - |
Sichuan Kelun Pharmacy Institute Co., Ltd.
 Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Director/Miembro de la Junta | 05/11/2020 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 4 |
|---|---|
Sichuan Kelun Pharmaceutical Co., Ltd.
 Sichuan Kelun Pharmaceutical Co., Ltd. BiotechnologyHealth Technology Manufactures and distributes intravenous solution products | Health Technology |
Chengdu Nymph Group Co., Ltd.
Chengdu Nymph Group Co., Ltd. Chengdu Nymph Group Co., Ltd. is a large integrated joint-stock enterprise specializing in the research, development, production, and sales of daily chemical products, focusing primarily on detergents and personal care products. The company integrates advanced production technology with traditional herbal knowledge and collaborates with institutions like Chengdu University of Traditional Chinese Medicine. The company is based in Chengdu, China. The Chinese company operates two major production bases, employs over 580 people including more than 220 technical professionals, and holds multiple production licenses and certifications such as ISO9001, ISO14001, and ISO45001. Its brands include detergent lines like "Red Rose," "Red Hibiscus," and "Double Cat," as well as cosmetic and personal care brands such as "Chunjuan," "Chunjuan Huangqi," "Chunjuan Baby," "Forest Morning," "Urban Baby," and "Dushi Beibei." Its marketing network covers over 235,000 sales outlets nationwide, with detergents mainly distributed in the southwest and cosmetics reaching all provinces. | |
Sichuan Kelun Pharmacy Institute Co., Ltd.
Sichuan Kelun Pharmacy Institute Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures medicines | Health Technology |
Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
 Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes drugs for treatment | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
